InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the full record of transactions filed by Aker Christopher Ray, Vice-Président Senior et Conseiller Juridique Général. Insider active across 2 companies, notably Regulus Therapeutics Inc.. Aggregated, 2 filings have been recorded. Total volume traded: €1k. The latest transaction was disclosed on 17 May 2021 — Cession. Regulator: SEC (Form 4). The full history is free.
Declarations2 total
€630860 shares@ €0.7321100.0% of flow
Common Stock
SEC:0001209191-21-033296·
€630860 shares@ €0.7321100.0% of flow
Common Stock
SEC:0001209191-21-033296:0·
2 of 2 declarations
About Aker Christopher Ray
Christopher Ray Aker is the Senior Vice President and General Counsel at Regulus Therapeutics Inc. He is responsible for managing the company's legal affairs, including regulatory compliance and intellectual property protection. His expertise in business law and regulation is essential to support Regulus Therapeutics' mission.
